Mouwasat Medical Services (4002) Stock Overview
Engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 4002 from our risk checks.
4002 Community Fair Values
Create NarrativeSee what 52 others think this stock is worth. Follow their fair value or set your own to get alerts.
Mouwasat Medical Services Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س69.75 |
| 52 Week High | ر.س95.40 |
| 52 Week Low | ر.س65.60 |
| Beta | 0.43 |
| 1 Month Change | -5.81% |
| 3 Month Change | -6.38% |
| 1 Year Change | -24.51% |
| 3 Year Change | -23.77% |
| 5 Year Change | 8.48% |
| Change since IPO | 870.43% |
Recent News & Updates
The Price Is Right For Mouwasat Medical Services Company (TADAWUL:4002)
Oct 21Mouwasat Medical Services (TADAWUL:4002) Hasn't Managed To Accelerate Its Returns
Sep 30Earnings Beat: Mouwasat Medical Services Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 07Recent updates
Shareholder Returns
| 4002 | SA Healthcare | SA Market | |
|---|---|---|---|
| 7D | 2.6% | 1.7% | -0.3% |
| 1Y | -24.5% | -21.9% | -12.6% |
Return vs Industry: 4002 underperformed the SA Healthcare industry which returned -21.9% over the past year.
Return vs Market: 4002 underperformed the SA Market which returned -12.6% over the past year.
Price Volatility
| 4002 volatility | |
|---|---|
| 4002 Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 4.6% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in SA Market | 7.3% |
| 10% least volatile stocks in SA Market | 2.5% |
Stable Share Price: 4002 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 4002's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | n/a | Nasser Sultan Al-Subaie | www.mouwasat.com |
Mouwasat Medical Services Company, together with its subsidiaries, engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. The company operates a network of hospitals that provides medical services; and specialized centers, including eye, long term, rehabilitation, and cardiology centers, as well as stroke unit, nuclear medicine, fertility, diabetes and diabetic foot, skin care, and badana clinic. It also provides various services comprising inpatient pharmacy services, TPN and IV medication preparation units, chemotherapy medication preparation, anti-coagulant clinic, and clinical pharmacy services.
Mouwasat Medical Services Company Fundamentals Summary
| 4002 fundamental statistics | |
|---|---|
| Market cap | ر.س13.95b |
| Earnings (TTM) | ر.س755.51m |
| Revenue (TTM) | ر.س3.09b |
Is 4002 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4002 income statement (TTM) | |
|---|---|
| Revenue | ر.س3.09b |
| Cost of Revenue | ر.س1.77b |
| Gross Profit | ر.س1.32b |
| Other Expenses | ر.س567.02m |
| Earnings | ر.س755.51m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.78 |
| Gross Margin | 42.75% |
| Net Profit Margin | 24.42% |
| Debt/Equity Ratio | 26.3% |
How did 4002 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/07 23:38 |
| End of Day Share Price | 2025/12/07 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mouwasat Medical Services Company is covered by 24 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ibrahim Elaiwat | Aljazira Capital Company |
| Jassim Al-Jubran | Aljazira Capital Company |
| Rim Ben Salah Gharbi | AlphaMena |
